{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:21:08Z","timestamp":1790702468830,"version":"4.1.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T00:00:00Z","timestamp":1460505600000},"content-version":"vor","delay-in-days":378,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancercell.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ccell.2015.03.007","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T07:40:50Z","timestamp":1428565250000},"page":"439-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":219,"title":["The Journey from Discoveries in Fundamental Immunology to Cancer Immunotherapy"],"prefix":"10.1016","volume":"27","author":[{"given":"Jacques\u00a0F.A.P.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Sadelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2015.03.007_bib1","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1158\/2326-6066.CIR-14-0095","article-title":"Selective inhibition of regulatory T\u00a0cells by targeting the PI3K-Akt pathway","volume":"2","author":"Abu-Eid","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ccell.2015.03.007_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib3","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.190.7.995","article-title":"An essential role for interleukin 10 in the function of regulatory T\u00a0cells that inhibit intestinal inflammation","volume":"190","author":"Asseman","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib4","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(70)92755-8","article-title":"Establishment of immunological competence in a child with congenital thymic aplasia by a graft of fetal thymus","volume":"1","author":"August","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2015.03.007_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature11071","article-title":"Melanoma genome sequencing reveals frequent PREX2 mutations","volume":"485","author":"Berger","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/269417a0","article-title":"In a radiation chimaera, host H-2 antigens determine immune responsiveness of donor cytotoxic cells","volume":"269","author":"Bevan","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1101\/SQB.1994.059.01.070","article-title":"Genes coding for tumor-specific rejection antigens","volume":"59","author":"Boon","year":"1994","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.ccell.2015.03.007_bib8","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/ncb3023","article-title":"An organized and functional thymus generated from FOXN1-reprogrammed fibroblasts","volume":"16","author":"Bredenkamp","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ccell.2015.03.007_bib9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm827","article-title":"Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15","volume":"9","author":"Brentjens","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib10","doi-asserted-by":"crossref","first-page":"77ra38","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T\u00a0cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib11","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1182\/blood.V96.5.1999","article-title":"Chimeric Fv-zeta or Fv-epsilon receptors are not sufficient to induce activation or cytokine production in peripheral T\u00a0cells","volume":"96","author":"Brocker","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2015.03.007_bib12","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/eji.1830230705","article-title":"New simplified molecular design for functional T\u00a0cell receptor","volume":"23","author":"Brocker","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib13","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1073\/pnas.92.17.7739","article-title":"High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes","volume":"92","author":"Bunnell","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2015.03.007_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/scientificamerican1162-50","article-title":"The thymus gland","volume":"207","author":"Burnet","year":"1962","journal-title":"Sci. Am."},{"key":"10.1016\/j.ccell.2015.03.007_bib15","first-page":"3","article-title":"Immunological surveillance in neoplasia","volume":"7","author":"Burnet","year":"1971","journal-title":"Transplant. Rev."},{"key":"10.1016\/j.ccell.2015.03.007_bib16","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1084\/jem.141.6.1376","article-title":"Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen","volume":"141","author":"Cantor","year":"1975","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib17","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1073\/pnas.94.5.1914","article-title":"A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening","volume":"94","author":"Chen","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2015.03.007_bib18","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1078-0432.CCR-11-3050","article-title":"Local delivery of interleukin-12 using T\u00a0cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice","volume":"18","author":"Chinnasamy","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2015.03.007_bib19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00262-012-1202-z","article-title":"CAR T\u00a0cells transform to trucks: chimeric antigen receptor-redirected T\u00a0cells engineered to deliver inducible IL-12 modulate the tumour stroma to combat cancer","volume":"61","author":"Chmielewski","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ccell.2015.03.007_bib20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3181\/00379727-122-31353","article-title":"Thymus-marrow cell combinations. Synergism in antibody production","volume":"122","author":"Claman","year":"1966","journal-title":"Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine"},{"key":"10.1016\/j.ccell.2015.03.007_bib21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrc3670","article-title":"Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy","volume":"14","author":"Coulie","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2015.03.007_bib23","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","article-title":"Breakthrough of the year 2013. Cancer immunotherapy","volume":"342","author":"Couzin-Frankel","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ccell.2015.03.007_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nri1148","article-title":"Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?","volume":"3","author":"Croft","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1084\/jem.119.5.837","article-title":"Studies on the recovery of the immune response in irradiated mice thymectomized in adult life","volume":"119","author":"Cross","year":"1964","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib26","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI31202","article-title":"Tregs and rethinking cancer immunotherapy","volume":"117","author":"Curiel","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2015.03.007_bib27","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T\u00a0cells and reduces regulatory T and myeloid cells within B16 melanoma tumors","volume":"107","author":"Curran","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2015.03.007_bib28","doi-asserted-by":"crossref","first-page":"24ra25","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T\u00a0cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature12428","article-title":"Stability and function of regulatory T\u00a0cells is maintained by a neuropilin-1-semaphorin-4a axis","volume":"501","author":"Delgoffe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/320232a0","article-title":"Transfer of specificity by murine alpha and beta T-cell receptor genes","volume":"320","author":"Dembi\u0107","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib31","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2015.03.007_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/imt.10.81","article-title":"Enhancing the specificity of T-cell cultures for adoptive immunotherapy of cancer","volume":"3","author":"Duong","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ccell.2015.03.007_bib33","series-title":"The Collected Papers of Paul Ehrlich","author":"Ehrlich","year":"1957"},{"key":"10.1016\/j.ccell.2015.03.007_bib34","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.90.2.720","article-title":"Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors","volume":"90","author":"Eshhar","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2015.03.007_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00820666","article-title":"The T-body approach: potential for cancer immunotherapy","volume":"18","author":"Eshhar","year":"1996","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.ccell.2015.03.007_bib36","unstructured":"European Society for Medical Oncology (2014). Immune checkpoint inhibitors provide antitumour activity across malignant diseases. http:\/\/www.esmo.org\/Conferences\/Past-Conferences\/ESMO-2014-Congress."},{"key":"10.1016\/j.ccell.2015.03.007_bib37","doi-asserted-by":"crossref","first-page":"ra172","DOI":"10.1126\/scitranslmed.3006597","article-title":"PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses","volume":"5","author":"Fedorov","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib38","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.4049\/jimmunol.161.6.2791","article-title":"Chimeric receptors providing both primary and costimulatory signaling in T\u00a0cells from a single gene product","volume":"161","author":"Finney","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.gene.2013.03.092","article-title":"Gene therapy of primary T\u00a0cell immunodeficiencies","volume":"525","author":"Fischer","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.ccell.2015.03.007_bib40","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V90.3.952","article-title":"Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes","volume":"90","author":"Gallardo","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2015.03.007_bib41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri1842","article-title":"Adoptive immunotherapy for cancer: building on success","volume":"6","author":"Gattinoni","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00262-006-0225-8","article-title":"Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T\u00a0cells and restores T and NK effector functions in end stage cancer patients","volume":"56","author":"Ghiringhelli","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ccell.2015.03.007_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1309","article-title":"NKT cells: what\u2019s in a name?","volume":"4","author":"Godfrey","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/321431a0","article-title":"Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor\/T3 complex","volume":"321","author":"Gold","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.neo.7900018","article-title":"Cancer patient T\u00a0cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen","volume":"1","author":"Gong","year":"1999","journal-title":"Neoplasia"},{"key":"10.1016\/j.ccell.2015.03.007_bib46","series-title":"Immunological Tolerance: A Reassessment of Mechanisms of the Immune Response","first-page":"136","article-title":"Discussion after Miller, J.F.A.P","author":"Good","year":"1969"},{"key":"10.1016\/j.ccell.2015.03.007_bib47","series-title":"Immunological Tolerance: A Reassessment of Mechanisms of the Immune Response","first-page":"164","article-title":"Discussion after Miller, J.F.A.P","author":"Gowans","year":"1969"},{"key":"10.1016\/j.ccell.2015.03.007_bib48","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/196651a0","article-title":"Initiation of immune responses by small lymphocytes","volume":"196","author":"Gowans","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3181\/00379727-78-19068","article-title":"Pathogenic properties, and \u201cvertical\u201d transmission of the mouse leukemia agent","volume":"78","author":"Gross","year":"1951","journal-title":"Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine"},{"key":"10.1016\/j.ccell.2015.03.007_bib50","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T\u00a0cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib51","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib52","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/356607a0","article-title":"CD28-mediated signalling co-stimulates murine T\u00a0cells and prevents induction of anergy in T-cell clones","volume":"356","author":"Harding","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/308149a0","article-title":"Isolation of cDNA clones encoding T\u00a0cell-specific membrane-associated proteins","volume":"308","author":"Hedrick","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib54","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes","volume":"2","author":"Heslop","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib55","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1535-6108(03)00113-2","article-title":"Adoptive immunotherapy: engineering T\u00a0cell responses as biologic weapons for tumor mass destruction","volume":"3","author":"Ho","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2015.03.007_bib56","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.4049\/jimmunol.167.11.6123","article-title":"Tumor-specific T\u00a0cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28\/CD3 zeta signaling receptor molecule","volume":"167","author":"Hombach","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib57","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/leu.2010.75","article-title":"Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma\/leukemia effects and safety","volume":"24","author":"Hoyos","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2015.03.007_bib58","first-page":"227","article-title":"Spontaneous nonthymic tumors in SCID mice","volume":"61","author":"Huang","year":"2011","journal-title":"Comp. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/251060a0","article-title":"B cell-derived immunoglobulin on activated mouse T lymphocytes","volume":"251","author":"Hudson","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib60","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.leu.2403302","article-title":"Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia","volume":"18","author":"Imai","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2015.03.007_bib61","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0092-8674(91)90314-O","article-title":"The cytoplasmic domain of the T\u00a0cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways","volume":"64","author":"Irving","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2015.03.007_bib62","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2015.03.007_bib63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coi.2015.01.002","article-title":"Designing chimeric antigen receptors to effectively and safely target tumors","volume":"33C","author":"Jensen","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib64","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T\u00a0cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib65","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0092-8674(87)90568-X","article-title":"T cell tolerance by clonal elimination in the thymus","volume":"49","author":"Kappler","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2015.03.007_bib66","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib67","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1084\/jem.156.6.1848","article-title":"A search for messenger RNA molecules bearing immunoglobulin VH nucleotide sequences in T\u00a0cells","volume":"156","author":"Kemp","year":"1982","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib68","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nbt955","article-title":"The ABCs of artificial antigen presentation","volume":"22","author":"Kim","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2015.03.007_bib69","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/253219a0","article-title":"Ly antigens as markers for functionally distinct subpopulations of thymus-derived lymphocytes of the mouse","volume":"253","author":"Kisielow","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nbt.2459","article-title":"Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T\u00a0cells","volume":"31","author":"Kloss","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2015.03.007_bib71","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrclinonc.2013.46","article-title":"Treating B-cell cancer with\u00a0T\u00a0cells expressing anti-CD19 chimeric antigen receptors","volume":"10","author":"Kochenderfer","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2015.03.007_bib72","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib73","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.188.4.619","article-title":"Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes","volume":"188","author":"Krause","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib74","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1093\/JI\/187.7.3459","article-title":"Pillars article: CD28 and CTLA-4 have opposing effects on the response of T\u00a0cells to stimulation. The journal of experimental medicine. 1995. 182: 459-465","volume":"187","author":"Krummel","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/icb.1975.3","article-title":"A new analysis of allogeneic interactions","volume":"53","author":"Lafferty","year":"1975","journal-title":"Aust. J. Exp. Biol. Med. Sci."},{"key":"10.1016\/j.ccell.2015.03.007_bib76","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ccell.2015.03.007_bib77","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T\u00a0cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2015.03.007_bib78","doi-asserted-by":"crossref","first-page":"8905","DOI":"10.1073\/pnas.88.20.8905","article-title":"T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins","volume":"88","author":"Letourneur","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2015.03.007_bib79","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nbt0102-70","article-title":"Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta \/CD28 receptor","volume":"20","author":"Maher","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2015.03.007_bib80","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/intimm\/7.7.1157","article-title":"Predominant expression of invariant V \u03b1 14+ TCR \u03b1 chain in NK1.1+ T\u00a0cell populations","volume":"7","author":"Makino","year":"1995","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib81","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1084\/jem.135.4.956","article-title":"Isolation and partial characterization of lymphocyte surface immunoglobulins","volume":"135","author":"Marchalonis","year":"1972","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib82","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1182\/blood-2009-09-241398","article-title":"IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T\u00a0cell-mediated rejection of systemic lymphoma in immunodeficient mice","volume":"115","author":"Markley","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2015.03.007_bib83","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T\u00a0cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib84","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1182\/blood.V83.7.1988.1988","article-title":"Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer","volume":"83","author":"Mavilio","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2015.03.007_bib85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/204151a0","article-title":"Pathogenesis of the post-neonatal thymectomy wasting syndrome","volume":"204","author":"McIntire","year":"1964","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib86","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/1831069a0","article-title":"Role of the thymus in murine leukaemia","volume":"183","author":"Miller","year":"1959","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.ccell.2015.03.007_bib87","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1038\/1841809a0","article-title":"Fate of subcutaneous thymus grafts in thymectomized mice inoculated with leukaemic filtrate","volume":"184","author":"Miller","year":"1959","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib88","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/187703a0","article-title":"Recovery of leukaemogenic agent from nonleukaemic tissues of thymectomized mice","volume":"187","author":"Miller","year":"1960","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib89","series-title":"Advances in Cancer Research","first-page":"291","article-title":"Etiology and pathogenesis of mouse leukemia","author":"Miller","year":"1961"},{"key":"10.1016\/j.ccell.2015.03.007_bib90","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0140-6736(61)90693-6","article-title":"Immunological function of the thymus","volume":"2","author":"Miller","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2015.03.007_bib91","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1098\/rspb.1962.0048","article-title":"Effect of neonatal thymectomy on the immunological responsiveness of the mouse","volume":"156","author":"Miller","year":"1962","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ccell.2015.03.007_bib92","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/1951318a0","article-title":"Immunological significance of the thymus of the adult mouse","volume":"195","author":"Miller","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib93","first-page":"140","article-title":"The thymus in relation to neoplasia","volume":"Volume 2","author":"Miller","year":"1967"},{"key":"10.1016\/j.ccell.2015.03.007_bib94","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nri2993","article-title":"The golden anniversary of the thymus","volume":"11","author":"Miller","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib95","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/216659a0","article-title":"The thymus and the precursors of antigen-reactive cells","volume":"216","author":"Miller","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib96","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1084\/jem.128.4.801","article-title":"Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes","volume":"128","author":"Miller","year":"1968","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib97","first-page":"3","article-title":"Thymus and antigen-reactive cells","volume":"1","author":"Miller","year":"1969","journal-title":"Transplant. Rev."},{"key":"10.1016\/j.ccell.2015.03.007_bib98","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/newbio230267a0","article-title":"Thymus-derived cells in mouse thoracic duct lymph","volume":"230","author":"Miller","year":"1971","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.ccell.2015.03.007_bib99","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/199920a0","article-title":"Effect of thymectomy on the induction of skin tumours by 3,4-benzopyrene","volume":"199","author":"Miller","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3181\/00379727-116-29237","article-title":"Influence of thymectomy on tumor induction by polyoma virus in C57BL mice","volume":"116","author":"Miller","year":"1964","journal-title":"Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine"},{"key":"10.1016\/j.ccell.2015.03.007_bib101","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/2081332a0","article-title":"Thymus and the production of antibody-plaque-forming cells","volume":"208","author":"Miller","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib102","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/214992a0","article-title":"Cellular basis of the immunological defects in thymectomized mice","volume":"214","author":"Miller","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib103","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1084\/jem.128.4.821","article-title":"Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes","volume":"128","author":"Mitchell","year":"1968","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib104","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.stem.2012.11.002","article-title":"Generation of rejuvenated antigen-specific T\u00a0cells by reprogramming to pluripotency and redifferentiation","volume":"12","author":"Nishimura","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ccell.2015.03.007_bib105","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0092-8674(85)90206-5","article-title":"Stimulation of the T3-T cell receptor complex induces a membrane-potential-sensitive calcium influx","volume":"40","author":"Oettgen","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2015.03.007_bib106","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/intimm\/dxm057","article-title":"PD-1 and PD-1 ligands: from discovery to clinical application","volume":"19","author":"Okazaki","year":"2007","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib107","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00262-010-0855-8","article-title":"Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity","volume":"59","author":"Ostrand-Rosenberg","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ccell.2015.03.007_bib108","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","article-title":"Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation","volume":"330","author":"Papadopoulos","year":"1994","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib109","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2015.03.007_bib110","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1182\/blood-2011-12-400044","article-title":"Tumor-targeted T\u00a0cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning","volume":"119","author":"Pegram","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2015.03.007_bib111","first-page":"943","article-title":"Immunosuppression and cancer","volume":"5","author":"Penn","year":"1973","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ccell.2015.03.007_bib112","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1084\/jem.183.6.2669","article-title":"A\u00a0critical role for transforming growth factor-\u03b2 but not intreleukin-4 in the suppression of T helper type 1-mediated colitis by CD45RB(low)CD4+ T\u00a0cells","volume":"183","author":"Powrie","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib113","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molimm.2012.03.023","article-title":"Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T\u00a0cells modified to express a PD1:CD28 chimeric receptor","volume":"51","author":"Prosser","year":"2012","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib114","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ccell.2015.03.007_bib115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/PPO.0000000000000031","article-title":"CD19-CAR trials","volume":"20","author":"Ramos","year":"2014","journal-title":"Cancer J."},{"key":"10.1016\/j.ccell.2015.03.007_bib116","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","article-title":"Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1","volume":"29","author":"Robbins","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2015.03.007_bib117","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0092-8674(91)90327-U","article-title":"Cellular immunity to HIV activated by CD4 fused to T\u00a0cell or Fc receptor polypeptides","volume":"64","author":"Romeo","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2015.03.007_bib118","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.3489291","article-title":"A new approach to the\u00a0adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes","volume":"233","author":"Rosenberg","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.ccell.2015.03.007_bib119","series-title":"Thymus and Self: Immunobiology of the Mouse Mutant Nude","author":"Rygaard","year":"1973"},{"key":"10.1016\/j.ccell.2015.03.007_bib120","first-page":"43","article-title":"The nude mouse vs. the hypothesis of immunological surveillance","volume":"28","author":"Rygaard","year":"1976","journal-title":"Transplant. Rev."},{"key":"10.1016\/j.ccell.2015.03.007_bib121","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc971","article-title":"Targeting tumours with genetically enhanced T lymphocytes","volume":"3","author":"Sadelain","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2015.03.007_bib122","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.coi.2009.02.009","article-title":"The promise and potential pitfalls of chimeric antigen receptors","volume":"21","author":"Sadelain","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib123","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ccell.2015.03.007_bib124","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1126\/science.1142331","article-title":"Emerging challenges in regulatory T\u00a0cell function and biology","volume":"317","author":"Sakaguchi","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ccell.2015.03.007_bib125","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1084\/jem.161.1.72","article-title":"Organ-specific autoimmune diseases induced in mice by elimination of T\u00a0cell subset. I. Evidence for the active participation of T\u00a0cells in natural self-tolerance; deficit of a T\u00a0cell subset as a possible cause of autoimmune disease","volume":"161","author":"Sakaguchi","year":"1985","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib126","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ccell.2015.03.007_bib127","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib128","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00262-008-0515-4","article-title":"Molecular mechanisms of MHC class I abnormalities and\u00a0APM components in human tumors","volume":"57","author":"Seliger","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ccell.2015.03.007_bib129","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib130","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1084\/jem.20130579","article-title":"Fc-dependent depletion of tumor-infiltrating regulatory T\u00a0cells co-defines the\u00a0efficacy of anti-CTLA-4 therapy against melanoma","volume":"210","author":"Simpson","year":"2013","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib131","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.cb.05.110189.002145","article-title":"The interleukin 2 receptor","volume":"5","author":"Smith","year":"1989","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.ccell.2015.03.007_bib132","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib133","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1084\/jem.137.5.1142","article-title":"Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution","volume":"137","author":"Steinman","year":"1973","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib134","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/nm1676","article-title":"T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection","volume":"13","author":"Stephan","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2015.03.007_bib135","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fimmu.2013.00244","article-title":"Role of T\u00a0cell receptor affinity in the efficacy and specificity of adoptive T\u00a0cell therapies","volume":"4","author":"Stone","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib136","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T\u00a0cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2015.03.007_bib137","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nbt.2678","article-title":"Generation of tumor-targeted human T lymphocytes from\u00a0induced pluripotent stem cells for cancer therapy","volume":"31","author":"Themeli","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2015.03.007_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2015.03.011","article-title":"New cell sources for T\u00a0cell engineering and adoptive immunotherapy","author":"Themeli","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ccell.2015.03.007_bib139","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0092-8674(86)90019-X","article-title":"The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides","volume":"44","author":"Townsend","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2015.03.007_bib140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2012.12.006","article-title":"Regeneration of human tumor antigen-specific T\u00a0cells from iPSCs derived from mature CD8(+) T\u00a0cells","volume":"12","author":"Vizcardo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ccell.2015.03.007_bib141","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/icb.1962.42","article-title":"The immunological role of different lymphoid organs in the chicken. I. Dissociation of immunological responsiveness","volume":"40","author":"Warner","year":"1962","journal-title":"Aust. J. Exp. Biol. Med. Sci."},{"key":"10.1016\/j.ccell.2015.03.007_bib142","doi-asserted-by":"crossref","first-page":"269756","DOI":"10.1155\/2012\/269756","article-title":"Coinhibitory molecules in autoimmune diseases","volume":"2012","author":"Watanabe","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib143","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10875-012-9689-9","article-title":"Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling","volume":"32","author":"Wilkie","year":"2012","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.ccell.2015.03.007_bib144","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T\u00a0cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ccell.2015.03.007_bib145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/312521a0","article-title":"Sequence and expression of transcripts of the human T-cell receptor \u03b2-chain genes","volume":"312","author":"Yoshikai","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2015.03.007_bib146","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1158\/0008-5472.CAN-06-3977","article-title":"Extrathymic generation of tumor-specific T\u00a0cells from genetically engineered human hematopoietic stem cells via Notch signaling","volume":"67","author":"Zhao","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2015.03.007_bib147","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/251547a0","article-title":"Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis","volume":"251","author":"Zinkernagel","year":"1974","journal-title":"Nature"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610815000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610815000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T22:50:01Z","timestamp":1747867801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610815000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":147,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1535610815000951"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2015.03.007","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Journey from Discoveries in Fundamental Immunology to Cancer Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2015.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}